Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade

According to the Global Cancer Observatory (http://gco.iarc.fr), primary lung cancer ranks as the most common tumor worldwide and the leading cause of cancer-related mortality. In 2020, 2.2 million new lung cancer cases were diagnosed, which comprises 12.2% of total cancers.

Bibliographic Details
Main Authors: Baraibar-Argota, I. (Iosune), Gil-Bazo, I. (Ignacio)
Format: info:eu-repo/semantics/doctoralThesis
Language:eng
Published: Universidad de Navarra 2021
Subjects:
Online Access:https://hdl.handle.net/10171/61070